Celldex Therapeutics (CLDX) Return on Assets [ROA] (2009 - 2026)
Celldex Therapeutics' Return on Assets [ROA] came in at -46.47% for Q2 2026, down 18.59 percentage points from -27.88% a year earlier but up 5.38 percentage points from the prior quarter.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Return on Assets [ROA] (2009 - 2026) Analysis & Trends
For FY2025, Celldex Therapeutics' Return on Assets [ROA] was -37.63%, down 12.53 percentage points from FY2024.
- Return on Assets [ROA] carries a five-year change of -4.30 percentage points (FY2020 to FY2025).
- Going back by year, Return on Assets [ROA] was -25.10% in FY2024 (+9.47 pp), -34.56% in FY2023 (-6.39 pp), -28.17% in FY2022 (-7.45 pp) and -20.72% in FY2021 (+12.60 pp).
- The five-year range for quarterly Return on Assets [ROA] is -51.84% (Q1 2026) to -15.59% (Q4 2021).
- Year-over-year, Return on Assets [ROA] has declined for six consecutive quarters, with an average year-over-year change of -6.71 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Assets [ROA] over five years came in Q3 2024 (a gain of 24.54 percentage points), and the weakest in Q1 2026 (a drop of 28.49 percentage points).
- Business Quant data shows CLDX's Return on Assets [ROA] at -51.84% (Q1 2026), -42.03% (Q4 2025) and -33.49% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | Celldex Therapeutics | 2.41 Bn | 69.14 Mn | - | -41.65% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -41.65% |
| Jun 30, 2026 | -46.78% |
| Mar 31, 2026 | -52.03% |
| Dec 31, 2025 | -41.98% |
| Sep 30, 2025 | -33.72% |
| Jun 30, 2025 | -27.66% |
| Mar 31, 2025 | -23.18% |
| Dec 31, 2024 | -19.54% |
| Sep 30, 2024 | -18.09% |
| Jun 30, 2024 | -17.56% |
| Mar 31, 2024 | -21.69% |
| Dec 31, 2023 | -37.37% |
| Sep 30, 2023 | -42.23% |
| Jun 30, 2023 | -35.47% |
| Mar 31, 2023 | -34.44% |
| Dec 31, 2022 | -31.29% |
| Sep 30, 2022 | -28.14% |
| Jun 30, 2022 | -24.83% |
| Mar 31, 2022 | -18.30% |
| Dec 31, 2021 | -15.74% |
API Access
Celldex Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CLDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "CLDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CLDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();